PittsburghV1, France, Analysis, bibRecord, 000185

Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives

Identifieur interne : 000185 ( France/Analysis ); précédent : 000184; suivant : 000186

Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives

Auteurs : Anthony Schapira [Royaume-Uni] ; C Warren Olanow [États-Unis] ; Timothy Greenamyre [États-Unis] ; Erwan Bezard [France]

Source :

Lancet [ 0140-6736 ] ; 2014-08-09.

RBID : Hal:hal-01215631

Abstract

Several important advances have been made in our understanding of the pathways that lead to cell dysfunction and death in Parkinson's disease and Huntington's disease. These advances have been informed by both direct analysis of the post-mortem brain and by study of the biological consequences of the genetic causes of these diseases. Some of the pathways that have been implicated so far include mitochondrial dysfunction, oxidative stress, kinase pathways, calcium dysregulation, inflammation, protein handling, and prion-like processes. Intriguingly, these pathways seem to be important in the pathogenesis of both diseases and have led to the identification of molecular targets for candidate interventions designed to slow or reverse their course. We review some recent advances that underlie putative therapies for neuroprotection in Parkinson's disease and Huntington's disease, and potential targets that might be exploited in the future. Although we will need to overcome important hurdles, especially in terms of clinical trial design, we propose several target pathways that merit further study. In Parkinson's disease, these targets include agents that might improve mitochondrial function or increase degradation of defective mitochondria, kinase inhibitors, calcium channel blockers, and approaches that interfere with the misfolding, templating, and transmission of α-synuclein. In Huntington's disease, strategies might also be directed at mitochondrial bioenergetics and turnover, the prevention of protein dysregulation, disruption of the interaction between huntingtin and p53 or huntingtin-interacting protein 1 to reduce apoptosis, and interference with expression of mutant huntingtin at both the nucleic acid and protein levels.

Url:

https://hal.archives-ouvertes.fr/hal-01215631

DOI: 10.1016

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Hal, to step Corpus: 000548
to stream Hal, to step Curation: 000548
to stream Hal, to step Checkpoint: 000206
to stream Main, to step Merge: 000697
to stream Main, to step Curation: 000697
to stream Main, to step Exploration: 000697
to stream France, to step Extraction: 000185

Links to Exploration step

Hal:hal-01215631

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives</title>
<author><name sortKey="Schapira, Anthony" sort="Schapira, Anthony" uniqKey="Schapira A" first="Anthony" last="Schapira">Anthony Schapira</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-95915" status="INCOMING"><orgName>Department of Clinical Neurosciences</orgName>
<desc><address><country key="GB"></country>
</address>
</desc>
<listRelation><relation active="#struct-300875" type="direct"></relation>
<relation active="#struct-310129" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-300875" type="direct"><org type="institution" xml:id="struct-300875" status="VALID">          <orgName>University College of London [London]</orgName>
          <orgName type="acronym">UCL</orgName>
          <desc>            <address>              <addrLine>Gower Street, London WC1E 6BT </addrLine>
              <country key="GB"></country>
            </address>
            <ref type="url">http://www.ucl.ac.uk/</ref>
          </desc>
        </org>
</tutelle>
<tutelle active="#struct-310129" type="direct"><org type="institution" xml:id="struct-310129" status="INCOMING"><orgName>Institute of Neurology</orgName>
<desc><address><country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
<affiliation wicri:level="1"><hal:affiliation type="department" xml:id="struct-439262" status="INCOMING"><orgName>Departments of Neurology and Neuroscience</orgName>
<desc><address><addrLine> New York, NY, USA.</addrLine>
<country key="US"></country>
</address>
</desc>
<listRelation><relation active="#struct-439261" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-439261" type="direct"><org type="institution" xml:id="struct-439261" status="INCOMING"><orgName>Mount Sinai School of Medicine, New York, NY, USA.</orgName>
<desc><address><country key="US"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Greenamyre, Timothy" sort="Greenamyre, Timothy" uniqKey="Greenamyre T" first="Timothy" last="Greenamyre">Timothy Greenamyre</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-439308" status="INCOMING"><orgName>Pittsburgh Institute for Neurodegenerative Diseases,</orgName>
<desc><address><country key="US"></country>
</address>
</desc>
<listRelation><relation active="#struct-421637" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-421637" type="direct"><org type="institution" xml:id="struct-421637" status="INCOMING"><orgName>University of Pittsburgh School of Medicine</orgName>
<desc><address><addrLine>3811 O'Hara Street - Pittsburgh, PA. 15213</addrLine>
<country key="US"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-244085" status="VALID"><orgName>Institut des Maladies Neurodégénératives [Bordeaux]</orgName>
<orgName type="acronym">IMN</orgName>
<desc><address><addrLine>Bât. 3b 1er étage 146 Rue Léo Saignat 33076 Bordeaux </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://imn-bordeaux.org/</ref>
</desc>
<listRelation><relation active="#struct-259761" type="direct"></relation>
<relation name="UMR5293" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-259761" type="direct"><org type="institution" xml:id="struct-259761" status="VALID"><orgName>Université de Bordeaux</orgName>
<orgName type="acronym">UB</orgName>
<desc><address><addrLine>35, place Pey Berland - 33076 Bordeaux</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u-bordeaux.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR5293" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID">          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>            <address>              <country key="FR"></country>
            </address>
            <ref type="url">http://www.cnrs.fr/</ref>
          </desc>
        </org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName><settlement type="city">Bordeaux</settlement>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
</placeName>
<orgName type="university">Université de Bordeaux</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01215631</idno>
<idno type="halId">hal-01215631</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01215631</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-01215631</idno>
<idno type="doi">10.1016</idno>
<date when="2014-08-09">2014-08-09</date>
<idno type="wicri:Area/Hal/Corpus">000548</idno>
<idno type="wicri:Area/Hal/Curation">000548</idno>
<idno type="wicri:Area/Hal/Checkpoint">000206</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000206</idno>
<idno type="wicri:doubleKey">0140-6736:2014:Schapira A:slowing:of:neurodegeneration</idno>
<idno type="wicri:Area/Main/Merge">000697</idno>
<idno type="wicri:Area/Main/Curation">000697</idno>
<idno type="wicri:Area/Main/Exploration">000697</idno>
<idno type="wicri:Area/France/Extraction">000185</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives</title>
<author><name sortKey="Schapira, Anthony" sort="Schapira, Anthony" uniqKey="Schapira A" first="Anthony" last="Schapira">Anthony Schapira</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-95915" status="INCOMING"><orgName>Department of Clinical Neurosciences</orgName>
<desc><address><country key="GB"></country>
</address>
</desc>
<listRelation><relation active="#struct-300875" type="direct"></relation>
<relation active="#struct-310129" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-300875" type="direct"><org type="institution" xml:id="struct-300875" status="VALID">          <orgName>University College of London [London]</orgName>
          <orgName type="acronym">UCL</orgName>
          <desc>            <address>              <addrLine>Gower Street, London WC1E 6BT </addrLine>
              <country key="GB"></country>
            </address>
            <ref type="url">http://www.ucl.ac.uk/</ref>
          </desc>
        </org>
</tutelle>
<tutelle active="#struct-310129" type="direct"><org type="institution" xml:id="struct-310129" status="INCOMING"><orgName>Institute of Neurology</orgName>
<desc><address><country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
<affiliation wicri:level="1"><hal:affiliation type="department" xml:id="struct-439262" status="INCOMING"><orgName>Departments of Neurology and Neuroscience</orgName>
<desc><address><addrLine> New York, NY, USA.</addrLine>
<country key="US"></country>
</address>
</desc>
<listRelation><relation active="#struct-439261" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-439261" type="direct"><org type="institution" xml:id="struct-439261" status="INCOMING"><orgName>Mount Sinai School of Medicine, New York, NY, USA.</orgName>
<desc><address><country key="US"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Greenamyre, Timothy" sort="Greenamyre, Timothy" uniqKey="Greenamyre T" first="Timothy" last="Greenamyre">Timothy Greenamyre</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-439308" status="INCOMING"><orgName>Pittsburgh Institute for Neurodegenerative Diseases,</orgName>
<desc><address><country key="US"></country>
</address>
</desc>
<listRelation><relation active="#struct-421637" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-421637" type="direct"><org type="institution" xml:id="struct-421637" status="INCOMING"><orgName>University of Pittsburgh School of Medicine</orgName>
<desc><address><addrLine>3811 O'Hara Street - Pittsburgh, PA. 15213</addrLine>
<country key="US"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-244085" status="VALID"><orgName>Institut des Maladies Neurodégénératives [Bordeaux]</orgName>
<orgName type="acronym">IMN</orgName>
<desc><address><addrLine>Bât. 3b 1er étage 146 Rue Léo Saignat 33076 Bordeaux </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://imn-bordeaux.org/</ref>
</desc>
<listRelation><relation active="#struct-259761" type="direct"></relation>
<relation name="UMR5293" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-259761" type="direct"><org type="institution" xml:id="struct-259761" status="VALID"><orgName>Université de Bordeaux</orgName>
<orgName type="acronym">UB</orgName>
<desc><address><addrLine>35, place Pey Berland - 33076 Bordeaux</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u-bordeaux.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR5293" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID">          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>            <address>              <country key="FR"></country>
            </address>
            <ref type="url">http://www.cnrs.fr/</ref>
          </desc>
        </org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName><settlement type="city">Bordeaux</settlement>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
</placeName>
<orgName type="university">Université de Bordeaux</orgName>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1016</idno>
<series><title level="j">Lancet</title>
<idno type="ISSN">0140-6736</idno>
<imprint><date type="datePub">2014-08-09</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Several important advances have been made in our understanding of the pathways that lead to cell dysfunction and death in Parkinson's disease and Huntington's disease. These advances have been informed by both direct analysis of the post-mortem brain and by study of the biological consequences of the genetic causes of these diseases. Some of the pathways that have been implicated so far include mitochondrial dysfunction, oxidative stress, kinase pathways, calcium dysregulation, inflammation, protein handling, and prion-like processes. Intriguingly, these pathways seem to be important in the pathogenesis of both diseases and have led to the identification of molecular targets for candidate interventions designed to slow or reverse their course. We review some recent advances that underlie putative therapies for neuroprotection in Parkinson's disease and Huntington's disease, and potential targets that might be exploited in the future. Although we will need to overcome important hurdles, especially in terms of clinical trial design, we propose several target pathways that merit further study. In Parkinson's disease, these targets include agents that might improve mitochondrial function or increase degradation of defective mitochondria, kinase inhibitors, calcium channel blockers, and approaches that interfere with the misfolding, templating, and transmission of α-synuclein. In Huntington's disease, strategies might also be directed at mitochondrial bioenergetics and turnover, the prevention of protein dysregulation, disruption of the interaction between huntingtin and p53 or huntingtin-interacting protein 1 to reduce apoptosis, and interference with expression of mutant huntingtin at both the nucleic acid and protein levels.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Aquitaine</li>
<li>Nouvelle-Aquitaine</li>
</region>
<settlement><li>Bordeaux</li>
</settlement>
<orgName><li>Université de Bordeaux</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Schapira, Anthony" sort="Schapira, Anthony" uniqKey="Schapira A" first="Anthony" last="Schapira">Anthony Schapira</name>
</noRegion>
</country>
<country name="États-Unis"><noRegion><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
</noRegion>
<name sortKey="Greenamyre, Timothy" sort="Greenamyre, Timothy" uniqKey="Greenamyre T" first="Timothy" last="Greenamyre">Timothy Greenamyre</name>
</country>
<country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/France/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000185 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000185 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Amérique
   |area=    PittsburghV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     Hal:hal-01215631
   |texte=   Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
}}

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021

	Serveur d'exploration sur Pittsburgh
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur Pittsburgh

Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives

Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri